litlas
ログインアカウント作成

David T. Teachey

2004–2025 年に発表

別表記
David T Teachey
140
論文数
27,279
被引用数
71
h 指数
135
i10 指数

被引用数

David T. Teachey の年別被引用数1990 年: 被引用 1 件1991 年: 被引用 3 件1994 年: 被引用 1 件1997 年: 被引用 1 件2000 年: 被引用 1 件2001 年: 被引用 2 件2003 年: 被引用 1 件2005 年: 被引用 4 件2006 年: 被引用 7 件2007 年: 被引用 7 件2008 年: 被引用 5 件2009 年: 被引用 35 件2010 年: 被引用 36 件2011 年: 被引用 49 件2012 年: 被引用 47 件2013 年: 被引用 140 件2014 年: 被引用 176 件2015 年: 被引用 369 件2016 年: 被引用 431 件2017 年: 被引用 511 件2018 年: 被引用 601 件2019 年: 被引用 1,255 件2020 年: 被引用 1,653 件2021 年: 被引用 1,706 件2022 年: 被引用 1,179 件2023 年: 被引用 975 件2024 年: 被引用 1,388 件2025 年: 被引用 760 件2026 年: 被引用 20 件1992〜1993 年は被引用が無いため表示していません1995〜1996 年は被引用が無いため表示していません1998〜1999 年は被引用が無いため表示していません2002 年は被引用が無いため表示していません2004 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 3,849 件、この内訳の 32%中国: 引用元論文 1,444 件、この内訳の 12%ドイツ: 引用元論文 751 件、この内訳の 6.2%イギリス: 引用元論文 601 件、この内訳の 5%イタリア: 引用元論文 574 件、この内訳の 4.8%フランス: 引用元論文 444 件、この内訳の 3.7%カナダ: 引用元論文 338 件、この内訳の 2.8%スペイン: 引用元論文 298 件、この内訳の 2.5%オーストラリア: 引用元論文 281 件、この内訳の 2.3%スイス: 引用元論文 272 件、この内訳の 2.3%オランダ: 引用元論文 266 件、この内訳の 2.2%日本: 引用元論文 242 件、この内訳の 2%
0%32%その他 22.2%

機関

分野

  • Medicine81.2%
  • Biochemistry, Genetics and Molecular Biology10.2%
  • Immunology and Microbiology6.5%
  • Engineering0.9%
  • Materials Science0.2%
  • Neuroscience0.2%
  • その他0.8%

トピック

  • CAR-T cell therapy research19.6%
  • Immune Cell Function and Interaction6.3%
  • Virus-based gene therapy research5.8%
  • Acute Lymphoblastic Leukemia research4.4%
  • Nanowire Synthesis and Applications3.9%
  • Immunotherapy and Immune Responses3.7%
  • その他56.3%

共著者

全論文

検索で開く
  1. Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia

    著者: Shannon L. Maude, Noelle V. Frey, Pamela A. Shaw, Richard Aplenc, David M. Barrett, Nancy Bunin, Anne Chew, Vanessa Gonzalez, Zhaohui Zheng, Simon F. Lacey, Yolanda D. Mahnke, J. Joseph Melenhorst, Susan R. Rheingold, Angela Shen, David T. Teachey, Bruce L. Levine, Carl H. June, David L. Porter, Stephan A. Grupp - New England Journal of Medicine 2014 被引用: 5,408

  2. Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid Leukemia

    著者: Stephan A. Grupp, Michael Kalos, David M. Barrett, Richard Aplenc, David L. Porter, Susan R. Rheingold, David T. Teachey, Anne Chew, Bernd Hauck, J. Fraser Wright, Michael C. Milone, Bruce L. Levine, Carl H. June - New England Journal of Medicine 2013 被引用: 3,491

  3. Immune Effector Cell-Associated Hemophagocytic Lymphohistiocytosis-Like Syndrome

    著者: Melissa Hines, Tristan Knight, Kevin O. McNerney, Mark B. Leick, Tania Jain, Sairah Ahmed, Matthew J. Frigault, Joshua A. Hill, Michael D. Jain, William T. Johnson, Yi Lin, Kris M. Mahadeo, Gabriela Marón, Rebecca Marsh, Sattva S. Neelapu, Sarah Nikiforow, Amanda K. Ombrello, Nirav N. Shah, Aimee C. Talleur, David P Turicek, Anant Vatsayan, Sandy W. Wong, Marcela V. Maus, Krishna V. Komanduri, Nancy Berliner, Jan‐Inge Henter, Miguel‐Angel Perales, Noelle V. Frey, David T. Teachey, Matthew J. Frank, Nirali N. Shah - Transplantation and Cellular Therapy 2023 被引用: 304

  4. Identification of Predictive Biomarkers for Cytokine Release Syndrome after Chimeric Antigen Receptor T-cell Therapy for Acute Lymphoblastic Leukemia

    著者: David T. Teachey, Simon F. Lacey, Pamela A. Shaw, J. Joseph Melenhorst, Shannon L. Maude, Noelle V. Frey, Edward Pequignot, Vanessa Gonzalez, Fang Chen, Jeffrey Finklestein, David M. Barrett, Scott L. Weiss, Julie C. Fitzgerald, Robert A. Berg, Richard Aplenc, Colleen Callahan, Susan R. Rheingold, Zhaohui Zheng, Stefan Rose‐John, Jason C. White, Farzana Nazimuddin, Gerald Wertheim, Bruce L. Levine, Carl H. June, David L. Porter, Stephan A. Grupp - Cancer Discovery 2016 被引用: 1,084

  5. Chimeric Receptors Containing CD137 Signal Transduction Domains Mediate Enhanced Survival of T Cells and Increased Antileukemic Efficacy In Vivo

    著者: Michael C. Milone, Jonathan D. Fish, Carmine Carpenito, Richard G. Carroll, Gwendolyn K. Binder, David T. Teachey, Minu Samanta, Mehdi Lakhal, Brian Gloss, Gwenn Danet-Desnoyers, Dario Campana, James L. Riley, Stephan A. Grupp, Carl H. June - Molecular Therapy 2009 被引用: 1,189

  6. Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune effector cell-related adverse events

    著者: Marcela V. Maus, S. Alexander, Michael R. Bishop, Jennifer N. Brudno, Colleen Callahan, Marco L. Davila, Claudia Diamonte, Jörg Dietrich, Julie C. Fitzgerald, Matthew J. Frigault, Terry J. Fry, Jennifer Holter‐Chakrabarty, Krishna V. Komanduri, Daniel W Lee, Frederick L. Locke, Shannon L. Maude, Philip L. McCarthy, Elena Mead, Sattva S. Neelapu, Tomas G. Neilan, Bianca Santomasso, Elizabeth J. Shpall, David T. Teachey, Cameron J. Turtle, Tom Whitehead, Stephan A. Grupp - Journal for ImmunoTherapy of Cancer 2020 被引用: 269

  7. Gene Therapy in Patients with Transfusion-Dependent β-Thalassemia

    著者: Alexis A. Thompson, Mark C. Walters, Janet L. Kwiatkowski, John E.J. Rasko, Jean‐Antoine Ribeil, Suradej Hongeng, Elisa Magrin, Gary J. Schiller, Emmanuel Payen, Michaëla Semeraro, Despina Moshous, François Lefrère, Hervé Puy, Philippe Bourget, Alessandra Magnani, Laure Caccavelli, Jean‐Sébastien Diana, Felipe Suarez, Fabrice Monpoux, Valentine Brousse, Catherine Poirot, Chantal Brouzes, Jean–François Méritet, Corinne Pondarré, Yves Beuzard, Stany Chrétien, Thibaud Lefèbvre, David T. Teachey, Usanarat Anurathapan, P. Joy Ho, Christof von Kalle, Morris Kletzel, Elliott Vichinsky, Sandeep Soni, Gábor Veres, Olivier Nègre, Robert W. Ross, David Davidson, Alexandria Petrusich, Laura Sandler, Mohammed Asmal, Olivier Hermine, Mariane De Montalembert, Salima Hacein‐Bey‐Abina, Stéphane Blanche, Philippe Leboulch, Marina Cavazzana - New England Journal of Medicine 2018 被引用: 661

  8. Cytokine Release Syndrome After Chimeric Antigen Receptor T Cell Therapy for Acute Lymphoblastic Leukemia

    著者: Julie C. Fitzgerald, Scott L. Weiss, Shannon L. Maude, David M. Barrett, Simon F. Lacey, J. Joseph Melenhorst, Pamela A. Shaw, Robert A. Berg, Carl H. June, David L. Porter, Noelle V. Frey, Stephan A. Grupp, David T. Teachey - Critical Care Medicine 2016 被引用: 455

  9. Risk-Adapted Preemptive Tocilizumab to Prevent Severe Cytokine Release Syndrome After CTL019 for Pediatric B-Cell Acute Lymphoblastic Leukemia: A Prospective Clinical Trial

    著者: Stephan Kadauke, Regina M. Myers, Yimei Li, Richard Aplenc, Diane Baniewicz, David M. Barrett, Allison Barz Leahy, Colleen Callahan, J. Gregory Dolan, Julie C. Fitzgerald, Whitney L. Gladney, Simon F. Lacey, Hongyan Liu, Shannon L. Maude, Regina McGuire, Laura Motley, David T. Teachey, Gerald Wertheim, Lisa Wray, Amanda M. DiNofia, Stephan A. Grupp - Journal of Clinical Oncology 2021 被引用: 212

  10. Humanized CD19-Targeted Chimeric Antigen Receptor (CAR) T Cells in CAR-Naive and CAR-Exposed Children and Young Adults With Relapsed or Refractory Acute Lymphoblastic Leukemia

    著者: Regina M. Myers, Yimei Li, Allison Barz Leahy, David M. Barrett, David T. Teachey, Colleen Callahan, Christina Fasano, Susan R. Rheingold, Amanda M. DiNofia, Lisa Wray, Richard Aplenc, Diane Baniewicz, Hongyan Liu, Pamela A. Shaw, Edward Pequignot, Kelly Getz, Jennifer L. Brogdon, Andrew D. Fesnak, Donald L. Siegel, Megan M. Davis, Chelsie Bartoszek, Simon F. Lacey, Elizabeth O. Hexner, Anne Chew, Gerald Wertheim, Bruce L. Levine, Carl H. June, Stephan A. Grupp, Shannon L. Maude - Journal of Clinical Oncology 2021 被引用: 187

  11. CD19-targeted chimeric antigen receptor T-cell therapy for acute lymphoblastic leukemia

    著者: Shannon L. Maude, David T. Teachey, David L. Porter, Stephan A. Grupp - Blood 2015 被引用: 720

  12. Cytosine base editing enables quadruple-edited allogeneic CART cells for T-ALL

    著者: Caroline Diorio, Ryan Murray, Mark Naniong, Luis Barrera, Adam J. Camblin, John Chukinas, Lindsey Coholan, Aaron Edwards, Tori J. Fuller, Claudia Gonzales, Stephan A. Grupp, Alden Ladd, Melissa Le, Angelica Messana, Faith Musenge, Haley Newman, Yeh‐Chuin Poh, Henry Poulin, Theresa Ryan, Rawan Shraim, Sarah K. Tasian, Tiffaney L. Vincent, Lauren Young, Yingying Zhang, Giuseppe Ciaramella, Jason M. Gehrke, David T. Teachey - Blood 2022 被引用: 131

  13. Cytokine release syndrome after blinatumomab treatment related to abnormal macrophage activation and ameliorated with cytokine-directed therapy

    著者: David T. Teachey, Susan R. Rheingold, Shannon L. Maude, Gerhard Zugmaier, David M. Barrett, Alix E. Seif, Kim E. Nichols, Erica Suppa, Michael Kalos, Robert A. Berg, Julie C. Fitzgerald, Richard Aplenc, Lia Gore, Stephan A. Grupp - Blood 2013 被引用: 617

  14. T-cell acute lymphoblastic leukemia

    著者: Elizabeth A. Raetz, David T. Teachey - Hematology 2016 被引用: 308

  15. Comparative features and outcomes between paediatric T-cell and B-cell acute lymphoblastic leukaemia

    著者: David T. Teachey, Ching‐Hon Pui - The Lancet Oncology 2019 被引用: 291

  16. Managing Cytokine Release Syndrome Associated With Novel T Cell-Engaging Therapies

    著者: Shannon L. Maude, David M. Barrett, David T. Teachey, Stephan A. Grupp - The Cancer Journal 2014 被引用: 758

  17. Tocilizumab for the treatment of chimeric antigen receptor T cell-induced cytokine release syndrome

    著者: Chelsea Kotch, David M. Barrett, David T. Teachey - Expert Review of Clinical Immunology 2019 被引用: 327

  18. Network-based systems pharmacology reveals heterogeneity in LCK and BCL2 signaling and therapeutic sensitivity of T-cell acute lymphoblastic leukemia

    著者: Yoshihiro Gocho, Jingjing Liu, Jianzhong Hu, Wentao Yang, Neekesh V. Dharia, Jingliao Zhang, Hao Shi, Guoqing Du, August John, Ting-Nien Lin, Jeremy P. Hunt, Xin Huang, Bensheng Ju, Lauren Rowland, Lei Shi, Dylan Maxwell, Brandon Smart, Kristine R. Crews, Wenjian Yang, Kohei Hagiwara, Yingchi Zhang, Kathryn G. Roberts, Hong Wang, Elias Jabbour, Wendy Stock, Bartholomew J. Eisfelder, Elisabeth Paietta, Scott Newman, Giovanni Roti, Mark R. Litzow, John Easton, Jinghui Zhang, Junmin Peng, Hongbo Chi, Stanley Pounds, Mary V. Relling, Hiroto Inaba, Xiaofan Zhu, Steven M. Kornblau, Ching‐Hon Pui, Marina Konopleva, David T. Teachey, Charles G. Mullighan, Kimberly Stegmaier, William E. Evans, Jiyang Yu, Jun J. Yang - Nature Cancer 2021 被引用: 157

  19. CD38 as a pan-hematologic target for chimeric antigen receptor T cells

    著者: Tina Glisovic‐Aplenc, Caroline Diorio, John Chukinas, Kimberly Veliz, Olga Shestova, Feng Shen, Selene Nuñez-Cruz, Tiffaney L. Vincent, Fei Miao, Michael C. Milone, Carl H. June, David T. Teachey, Sarah K. Tasian, Richard Aplenc, Saar Gill - Blood Advances 2023 被引用: 60

  20. Comprehensive Serum Proteome Profiling of Cytokine Release Syndrome and Immune Effector Cell–Associated Neurotoxicity Syndrome Patients with B-Cell ALL Receiving CAR T19

    著者: Caroline Diorio, Rawan Shraim, Regina M. Myers, Edward M. Behrens, Scott Canna, Hamid Bassiri, Richard Aplenc, Chakkapong Burudpakdee, Fang Chen, Amanda M. DiNofia, Saar Gill, Vanessa Gonzalez, Michele P. Lambert, Allison Barz Leahy, Bruce L. Levine, Robert B. Lindell, Shannon L. Maude, J. Joseph Melenhorst, Haley Newman, Jessica Perazzelli, Alix E. Seif, Simon F. Lacey, Carl H. June, David M. Barrett, Stephan A. Grupp, David T. Teachey - Clinical Cancer Research 2022 被引用: 65

  21. Allogeneic chimeric antigen receptor cell therapies for cancer: progress made and remaining roadblocks

    著者: Caroline Diorio, David T. Teachey, Stephan A. Grupp - Nature Reviews Clinical Oncology 2024 被引用: 67

  22. Children's Oncology Group Trial AALL1231: A Phase III Clinical Trial Testing Bortezomib in Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia and Lymphoma

    著者: David T. Teachey, Meenakshi Devidas, Brent L. Wood, Zhiguo Chen, Robert J. Hayashi, Michelle L. Hermiston, Robert D. Annett, Jan-Michael Archer, Barbara L. Asselin, Keith J. August, Steve Y. Cho, Kimberly P. Dunsmore, Brian T. Fisher, Jason L. Freedman, Paul J. Galardy, Paul Harker‐Murray, Terzah M. Horton, Alok Jaju, Allison Lam, Yoav H. Messinger, Rodney R. Miles, Maki Okada, Samir Patel, Eric S. Schafer, Tal Schechter, Neelam Singh, Amii C. Steele, Maria Luisa Sulis, Sarah Vargas, Stuart S. Winter, Charlotte Wood, Patrick A. Zweidler‐McKay, Catherine M. Bollard, Mignon L. Loh, Stephen P. Hunger, Elizabeth A. Raetz - Journal of Clinical Oncology 2022 被引用: 148

  23. The genomic basis of childhood T-lineage acute lymphoblastic leukaemia

    著者: Petri Pölönen, Danika Di Giacomo, Anna Eames Seffernick, Abdelrahman Elsayed, Shunsuke Kimura, Francesca Benini, Lindsey E. Montefiori, Brent L. Wood, Jason Xu, Changya Chen, Zhongshan Cheng, Haley Newman, Jason R. Myers, Ilaria Iacobucci, Elizabeth Li, Jonathan Sussman, Dale J. Hedges, Yawei Hui, Caroline Diorio, Lahari Uppuluri, David B. Frank, Yiping Fan, Yunchao Chang, Soheil Meshinchi, Rhonda E. Ries, Rawan Shraim, Alexander Li, Kathrin M. Bernt, Meenakshi Devidas, Stuart S. Winter, Kimberly P. Dunsmore, Hiroto Inaba, William L. Carroll, Nilsa C. Ramirez, Aaron H. Phillips, Richard W. Kriwacki, Jun J. Yang, Tiffaney L. Vincent, Yaqi Zhao, Pankaj S. Ghate, Jian Wang, Colleen Reilly, Xin Zhou, Mathijs A. Sanders, Junko Takita, Motohiro Kato, Nao Takasugi, Bill H. Chang, Richard D. Press, Mignon L. Loh, Evadnie Rampersaud, Elizabeth A. Raetz, Stephen P. Hunger, Kai Tan, Ti‐Cheng Chang, Gang Wu, Stanley Pounds, Charles G. Mullighan, David T. Teachey - Nature 2024 被引用: 137

  24. Prognostic significance of ETP phenotype and minimal residual disease in T-ALL: a Children’s Oncology Group study

    著者: Brent L. Wood, Meenakshi Devidas, Ryan J. Summers, Zhiguo Chen, Barbara L. Asselin, Karen R. Rabin, Patrick A. Zweidler‐McKay, Naomi Winick, Michael J. Borowitz, William L. Carroll, Elizabeth A. Raetz, Mignon L. Loh, Stephen P. Hunger, Kimberly P. Dunsmore, David T. Teachey, Stuart S. Winter - Blood 2023 被引用: 58